Does PEMBROLIZUMAB Cause Neoplasm progression? 526 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 526 reports of Neoplasm progression have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.6% of all adverse event reports for PEMBROLIZUMAB.
526
Reports of Neoplasm progression with PEMBROLIZUMAB
0.6%
of all PEMBROLIZUMAB reports
172
Deaths
145
Hospitalizations
How Dangerous Is Neoplasm progression From PEMBROLIZUMAB?
Of the 526 reports, 172 (32.7%) resulted in death, 145 (27.6%) required hospitalization, and 35 (6.7%) were considered life-threatening.
Is Neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PEMBROLIZUMAB. However, 526 reports have been filed with the FAERS database.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Neoplasm progression?
PALBOCICLIB (10,885)
SUNITINIB MALATE (1,920)
CYCLOPHOSPHAMIDE (1,588)
CARBOPLATIN (1,370)
AXITINIB (1,315)
DOXORUBICIN (1,276)
LETROZOLE (1,225)
PACLITAXEL (1,180)
CRIZOTINIB (1,161)
VINCRISTINE (1,106)
Which PEMBROLIZUMAB Alternatives Have Lower Neoplasm progression Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G